| 英文别名 |
Butanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-;N-butyroyl-D-erythro-sphingosine;N-Butanoyl-D-erythro-sphingosine;C4 Ceramide;N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]butanamide;NULL;Butyl Ceramide;N-Butyl-D-sphingosine;(2S,3R,4E)-2-(Butyrylamino)-4-octadecene-1,3-diol;N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]butanamide;C4-Ceramide;C4 Ceramide (d18:1/4:0);N-Butyroyl-D-erythro-sphingosine;N-Butyryl-D-sphingosine, >=98.0% (TLC);CS-0455461;N-Butyryl-D-erythro-sphingosine;C4 Ceramide (d18:1/4:0), N-butyroyl-D-erythro-sphingosine, powder;Ceramide 4 (retired) [INCI];Q27289174;AS-56315;SCHEMBL14032269;AKOS037645030;Ceramide as (ceramide 4) [INCI];74713-58-9;SF3LP91341;Butanamide, N-((1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl)-;Butanamide, N-(2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl)-, (R-(R*,S*-(E)))-;N-[(E,2S,3R)-1,3-DIHYDROXYOCTADEC-4-EN-2-YL] BUTANAMIDE;DTXSID70420650;N-((2S,3R,E)-1,3-dihydroxyoctadec-4-en-2-yl)butyramide;Ceramide 4;UNII-SF3LP91341;BP-28806;Ceramide as (ceramide 4) |
微信公众号
客服
C4%3dCN%3dC(C%3dC4C(F)F)N)N5%5bC%40%40H%5d6CC%5bC%40H%5d5COC6)
